Method of identifying natural antibodies for remyelination

Journal of Clinical Immunology

Volumn 30, Issue SUPPL. 1, 2010, Pages

  Warrington, Arthur E ^a   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

Author keywords

Multiple sclerosis; Recombinant human antibodies; Remyelination; Theiler's murine encephalomyelitis virus

Indexed keywords

ANTIBODY; FERRITIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; LIPID; MONOCLONAL ANTIBODY; MYELIN PROTEIN; RECOMBINANT ANTIBODY; AUTOANTIBODY; HYBRID PROTEIN; MEMBRANE LIPID;

ALZHEIMER DISEASE; ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIGEN RECOGNITION; CELL PROLIFERATION; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BINDING; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG TARGETING; EXPRESSION VECTOR; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; IN VIVO STUDY; LOW DRUG DOSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; REMYELINIZATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; ANIMAL; BLOOD BRAIN BARRIER; CARDIOVIRUS INFECTIONS; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISEASE MODEL; IMMUNOLOGY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; MYELIN SHEATH; PHYSIOLOGY; REGENERATION; SPINAL CORD; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; BLOOD-BRAIN BARRIER; CARDIOVIRUS INFECTIONS; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNOGLOBULIN M; MEMBRANE LIPIDS; MICE; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; RECOMBINANT FUSION PROTEINS; REGENERATION; SPINAL CORD; THEILOVIRUS;

EID: 77956182275     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9406-5     Document Type: Review

References (22)

1. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995;7:812-818
2. Avrameas S, Ternynck T, Tsonis IA, Lymberi P. Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun. 2007;29:213-218
3. Rodriguez M, Oleszak E, Leibowitz J. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol. 1987;7:325-365
4. McGavern DB, Murray PD, Rivera-Quinones C, Schmelzer JD, Low PA, Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain. 2000;123(Pt 3):519-531
5. Rodriguez M, Lennon VA, Benveniste EN, Merrill JE. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol. 1987;46:84-95.
6. Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system. Ann Neurol. 1990;27:12-17
7. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci. 1994;14:6230-6238
8. Asakura K, Miller DJ, Pease LR, Rodriguez M. Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci. 1998;18:7700-7708
9. Warrington AE, Asakura K, Bieber AJ, Ciric B, Van Keulen V, Kaveri SV, et al. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A. 2000;97:6820-6825
10. Miller DJ, Njenga MK, Parisi JE, Rodriguez M. Multi-organ reactivity of a monoclonal natural autoantibody that promotes remyelination in a mouse model of multiple sclerosis. J Histochem Cytochem. 1996;44:1005-1011
11. Rodriguez M, Warrington AE, Pease LR. Invited article: human natural autoantibodies in the treatment of neurologic disease. Neurology. 2009;72:1269-1276
12. Mitsunaga Y, Ciric B, Van Keulen V, Warrington AE, Paz Soldan M, Bieber AJ, et al. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J. 2002;16:1325-1327
13. Bieber AJ, Warrington A, Asakura K, Ciric B, Kaveri SV, Pease LR, et al. Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia. 2002;37:241-249
14. Warrington AE, Bieber AJ, Ciric B, Pease LR, Van Keulen V, Rodriguez M. A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res. 2007;85:967-976
15. Pirko I, Ciric B, Gamez J, Bieber AJ, Warrington AE, Johnson AJ, et al. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J. 2004;18:1577-1579
16. Ciric B, Van Keulen V, Paz Soldan M, Rodriguez M, Pease LR. Antibody-mediated remyelination operates through mechanism independent of immunomodulation. J Neuroimmunol. 2004;146:153-161
17. Rodriguez M, Lindsley MD. Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease. Neurology. 1992;42:348-357
18. Kozlowski GP, Sterzl I, Nilaver G. Localization patterns for immunoglobulins and albumins in the brain suggest diverse mechanisms for their transport across the blood-brain barrier (BBB). Prog Brain Res. 1992;91:149-154
19. Hunter SF, Miller DJ, Rodriguez M. Monoclonal remyelinationpromoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis. J Neurol Sci. 1997;150:103-113
20. Banks WA, Farr SA, Morley JE, Wolf KM, Geylis V, Steinitz M. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment. Exp Neurol. 2007;206:248-256
21. Paz Soldan MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, et al. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci. 2003;22:14-24.
22. Howe CL, Bieber AJ, Warrington AE, Pease LR, Rodriguez M. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis. 2004;15:120-131